Cannabigerol

Iconic International Cannabis Brand, COOKIES, Enters the CBD Flower Market

Retrieved on: 
Wednesday, May 19, 2021

b'International cannabis brand COOKIES now offers consumers nationwide new access to COOKIES premium products with the launch of its novel CBD Flower line .

Key Points: 
  • b'International cannabis brand COOKIES now offers consumers nationwide new access to COOKIES premium products with the launch of its novel CBD Flower line .
  • After diligently looking and testing hundreds of batches, COOKIES has found the right cultivators to produce exceptional and unique CBD Flower genetics.
  • COOKIES CBD Flower contains only 100% hand-trimmed buds, which are unaltered, cured and have no additives.\nSmoking or vaping hemp flower is ideal for those who want to reap the benefits of natural hemp compounds such as cannabidiol (CBD), cannabigerol (CBG) and other phytocannabinoids.
  • The company and its product are recognized globally and offer a collection of over 150 cannabis varieties and product lines including indoor and sungrown flower, pre-rolls, gel capsules, vape cartridges, medicinal mushrooms and CBD Flower.

Delta 10 THC - The Hemp Saga Grows

Retrieved on: 
Wednesday, May 19, 2021

Delta 10 THC is the latest cannabinoid to hit the market this year, following on the heels of Delta 8.\nDerived from hemp, certified labs have been able to obtain Delta 10 THC from the CBD rich plant.

Key Points: 
  • Delta 10 THC is the latest cannabinoid to hit the market this year, following on the heels of Delta 8.\nDerived from hemp, certified labs have been able to obtain Delta 10 THC from the CBD rich plant.
  • CBD, CBG, Delta 9, and Delta 8 are the most common cannabinoids derived from hemp and marijuana.
  • Delta 10 is reportedly almost double Delta 8 in terms of psychotropic potency, but concentrations of delta 10 are typically about half that of Delta 8, when in distillate form.
  • Delta 8 THC, Delta 10 THC, CBD, CBG, CBC, CBN and more to come.

Willow Biosciences Added to NYSE-Listed Cannabis ETF "THCX"

Retrieved on: 
Tuesday, May 18, 2021

"As we have just commenced the commercialization stage of our first cannabinoid, cannabigerol ("CBG"), this milestone comes at the perfect time as we are transitioning into a revenue generating company.

Key Points: 
  • "As we have just commenced the commercialization stage of our first cannabinoid, cannabigerol ("CBG"), this milestone comes at the perfect time as we are transitioning into a revenue generating company.
  • "\nListed on NYSE Arca, THCX tracks the Innovation Labs Cannabis Index, a portfolio of 33 stocks that are expected to benefit from the growth of the legal global marijuana, cannabidiol ("CBD") and hemp industries.
  • Willow\'s manufacturing process creates a consistent, scalable and sustainable product that benefits industry and consumers.
  • The forward-looking statements contained herein are expressly qualified by this cautionary statement.\nView original content to download multimedia: http://www.prnewswire.com/news-releases/willow-biosciences-added-to-nyse...\n'

Sweet Earth Completes Development of Proprietary CBD Cigarette

Retrieved on: 
Monday, May 17, 2021

Its products combine CBD with herbal and organic ingredients, all of which are selected for their beneficial properties to soothe, rejuvenate, and reduce inflammation.

Key Points: 
  • Its products combine CBD with herbal and organic ingredients, all of which are selected for their beneficial properties to soothe, rejuvenate, and reduce inflammation.
  • In addition to high-end finished products, Sweet Earth prides itself on sustainability by minimizing the use of plastics in both production and packaging.
  • Sweet Earth\'s in-house genetics team has been working on its own proprietary hemp strain.\nSweet Earth maintains a portfolio of skin and body care products that includes facial products, men\'s, spa, hemp, and muscle products that are sold on its website, https://sweetearthskincare.com .\nSweet Earth operates a proprietary online shopping portal for discerning pet owners offering pet treats comprised of high-quality ingredients, which are further enriched with CBD and Vitamin E. The treats are sold on its website: https://www.sweetearthpets.com .\nSweet Earth has created a line of CBD that cigarettes are made from 100% naturally grown US hemp flower that is rich in non-intoxicating cannabinoids like CBD and cannabigerol ("CBG").
  • The cigarettes are completely free of tobacco, nicotine, or additives.

Willow Biosciences Announces Completion of its First Commercial Scale Fermentation Run

Retrieved on: 
Wednesday, March 31, 2021

VANCOUVER,BC, March 31, 2021 /PRNewswire/ - Willow Biosciences Inc.("Willow" or the "Company") (TSX:WLLW) (OTCQX: CANSF) is pleased to announce that it has completed the first commercial scale fermentation run of its first cannabinoid for market, cannabigerol ("CBG").

Key Points: 
  • VANCOUVER,BC, March 31, 2021 /PRNewswire/ - Willow Biosciences Inc.("Willow" or the "Company") (TSX:WLLW) (OTCQX: CANSF) is pleased to announce that it has completed the first commercial scale fermentation run of its first cannabinoid for market, cannabigerol ("CBG").
  • "We are very pleased with the yield and quality of our first commercial scale fermentation run of CBG," said Trevor Peters, Willow's President and Chief Executive Officer.
  • We are now starting the next phase of Willow's lifecycle, which will involve supplying commercial quantities of cannabinoids to customers and recognizing revenue therefrom."
  • Production from our first commercial fermentation run is earmarked for sale to prospective customers and the Company is in the process of finalizing agreements with multiple parties.

Minor Cannabinoids Take Center Stage in New Suite of Consumer-friendly OTC Supplement Tablets

Retrieved on: 
Wednesday, February 17, 2021

CBD+CBN Instant Release Tablets (38mg CBD, 12mg CBN)

Key Points: 
  • CBD+CBN Instant Release Tablets (38mg CBD, 12mg CBN)
    Each Prolifera Instant Release Tablet is color coded per its minor cannabinoid formulation.
  • The new Prolifera line combines CBD with three of the most popular minor cannabinoids: CBN (cannabinol), CBG (cannabigerol) and CBC (cannabichromene).
  • The new Prolifera suite of CBD and minor cannabinoid tablets are created to meet this growing consumer need.
  • We understand that to succeed, we need to simplify using CBD and cannabinoids while we normalize its delivery method.

RETRANSMISSION: Sweet Earth Commences Key CBD Bioavailability Research

Retrieved on: 
Tuesday, February 16, 2021

Vancouver, British Columbia--(Newsfile Corp. - February 16, 2021) - Sweet Earth Holdings Corp. (CSE: SE) (FSE: 1KZ1) (OTCQB: SEHCF) ("Sweet Earth" the "Company") is pleased to announce it has commenced bioavailability research on CBD isolate and CBD broad spectrum particle size with NAVCO Pharmaceuticals Limited ("Navco"), an accredited laboratory located in Burlington, Ontario.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - February 16, 2021) - Sweet Earth Holdings Corp. (CSE: SE) (FSE: 1KZ1) (OTCQB: SEHCF) ("Sweet Earth" the "Company") is pleased to announce it has commenced bioavailability research on CBD isolate and CBD broad spectrum particle size with NAVCO Pharmaceuticals Limited ("Navco"), an accredited laboratory located in Burlington, Ontario.
  • As an industry leader in developing high-end CBD products for discerning customers, Sweet Earth is also committed to leading scientific research in the efficacy of CBD products as well.
  • Sweet Earth is committed to providing products that permeate the skin to provide superior efficacy.
  • Sweet Earth has created a line of CBD that cigarettes are made from 100% naturally grown US hemp flower that is rich in non-intoxicating cannabinoids like CBD and cannabigerol ("CBG").

Sweet Earth Commences Key CBD Bioavailability Research

Retrieved on: 
Tuesday, February 16, 2021

Vancouver, British Columbia--(Newsfile Corp. - February 16, 2021) - Sweet Earth Holdings Corp. (CSE: SE) (FSE: 1KZ1) (OTCQB: SEHCF) ("Sweet Earth" the "Company") is pleased to announce it has commenced bioavailability research on CBD isolate and CBD broad spectrum particle size with NAVCO Pharmaceuticals Limited ("Navco"), an accredited laboratory located in Burlington, Ontario.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - February 16, 2021) - Sweet Earth Holdings Corp. (CSE: SE) (FSE: 1KZ1) (OTCQB: SEHCF) ("Sweet Earth" the "Company") is pleased to announce it has commenced bioavailability research on CBD isolate and CBD broad spectrum particle size with NAVCO Pharmaceuticals Limited ("Navco"), an accredited laboratory located in Burlington, Ontario.
  • As an industry leader in developing high-end CBD products for discerning customers, Sweet Earth is also committed to leading scientific research in the efficacy of CBD products as well.
  • Sweet Earth is committed to providing products that permeate the skin to provide superior efficacy.
  • Sweet Earth has created a line of CBD that cigarettes are made from 100% naturally grown US hemp flower that is rich in non-intoxicating cannabinoids like CBD and cannabigerol ("CBG").

Ireland CBD Regulatory Report 2020: Import and Export Requirements, Medical Cannabis, Recreational Cannabis, Relevant Laws & Relevant Bodies - ResearchAndMarkets.com

Retrieved on: 
Tuesday, February 2, 2021

The "Regulatory Report: Ireland CBD" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Regulatory Report: Ireland CBD" report has been added to ResearchAndMarkets.com's offering.
  • This report provides a comprehensive overview of the current regulatory regime for CBD, hemp and it's products in Ireland, covering all aspects of law as well as providing a list of all relevant laws and bodies, and information relating to Ireland's medical cannabis rules.
  • Cannabis, THC and CBN (cannabinol) are controlled substances in Ireland under the Misuse of Drugs Act, but CBD (cannabidiol) and CBG (cannabigerol) are not.
  • Meanwhile, the use of cannabis for recreational purposes is prohibited, but the medical use of cannabis is allowed under certain conditions and requires a case-by-case approval by health authorities.

Amyris Acquiring Terasana Brand To Offer Clean Cannabinoid Consumer Products

Retrieved on: 
Friday, January 22, 2021

With Terasana, Amyris is focused on offering leading skincare applications formulated with unique natural cannabinoids that deliver high efficacy sustainable products direct to consumers.

Key Points: 
  • With Terasana, Amyris is focused on offering leading skincare applications formulated with unique natural cannabinoids that deliver high efficacy sustainable products direct to consumers.
  • This will further expand Amyris's presence in the clean beauty space beyond its Biossanceskincare, Pipettebaby and mother care, Rose Inc. clean cosmetics brand and recently announced Jonathan Van Ness partnership for a new clean haircare brand.
  • Through this platform, Amyris recently commercialized a clean, sustainable, fermentation based CBG (cannabigerol), a non-psychoactive cannabinoid.
  • Amyris, the Amyris logo, No Compromise, Biossance, Pipette, and Purecane are trademarks or registered trademarks of Amyris, Inc. in the U.S. and/or other countries.